tirzepatide surpass 4 SURPASS-4 trial: slows rate of eGFR decline and reduces UACR in T2DM patients Tirzepatide superior to insulin glargine
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16






























